drugset / Trial / NCT06898268

Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux

NCT06898268

Completed 290 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aimed to fill the gaps by comparing the efficacy and safety of ondansetron versus metoclopramide for the control of gastroesophageal reflux disorder in children 1-12 months of age, presenting at the outdoor department of Allama Iqbal Teaching Hospital, Dera Ghazi Khan.

Timeline

Start
2024-07-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule
Subject Ondansetron Other / unclassified Oral